Jump to content

BioProcess International Europe

Virtual Conference
July 13–16, 2020

Meet Genedata experts at BPI Europe.

Don't miss the opportunity to see how Genedata solutions efficiently support the whole biopharmaceutical R&D workflow, including screening and protein engineering, expression and purification, characterization and analysis of protein therapeutics, cell line design and development, bioprocess optimization, stratification of clinical trial subjects, quality control of biologicals, and NGS-based cell line development and biosafety.

To get more information about Genedata solutions, please contact info(at)genedata.com.

Recommended Oral Presentations

Accelerating the Path to Clinic: Merging Automation and Data Management Technology with Sartorius Stedim Cellca´s Cell Line and Process Development
Kristin Thiele, Manager of Product Development Team 1, Sartorius Stedim Cellca

Cell Line Development and Engineering Stream
Monday, July 13 | 11:40 am–12:00 pm

Despite the demand of ‘speed to clinic’ to bring new bio therapeutics into clinical trials, the CHO cell line development (CLD) process is associated with long development timelines, heavy manual workload and large data volumes. To overcome these obstacles in CLD sectors, we developed an accelerated, efficient and robust CLD platform, combined with flexible automated technologies and high-standard digital data management solutions. By leveraging our improved Sartorius Cellca CLD 4.0 platform we reliably generate high-yielding, stable and large-scale-cell compatible cell lines within 12 weeks. This is enabled by our integrated CLD, automation, and data management approach taking us to the next level of operational excellence.

Efficiency Gains by Integrating Automated and Manual Cell Line Development Workflows in One End-to-End Platform
Christoph Freiberg, Ph.D., Head of Product Management Biologics, Genedata

Cell Line Development and Engineering Stream
Thursday, July 16 | 11:20 am–11:40 am

We have developed an E2E platform that supports the entire bioprocess development workflow by automating cell line development and managing upstream process, downstream process, analytical and formulation development. The system directly integrates with instruments and enables informed decision-making via its query and reporting infrastructure. We present efficiency and quality gains in cell line and upstream process development as well as viral vector production.